Cellular Biomedicine Group Announces Completion of Patient Treatment...

Cellular Biomedicine Group, Inc. is pleased to announce that it has treated the final patient of its Phase I/IIa clinical trial for ReJoin , a human adipose-derived mesenchymal precursor cell therapy for Knee Osteoarthritis .

http://www.freshnews.com/news/865078/cellular-biomedicine-group-announces-completion-patient-treatment-phase-i-iia-clinical-